IL-18R Activators

IL-18R activators encompass a diverse array of chemical compounds that facilitate the augmentation of IL-18R's functional activity through distinct biochemical pathways. Anakinra, by blocking IL-1 receptor interaction, indirectly prioritizes IL-18R signaling by reducing the competitive effects of IL-1. This mechanism allows IL-18R to function more prominently in its role within the immune response. Similarly, Poly(I:C) and its TLR3 activation lead to a boost inIL-18R Activators encompass a diverse array of chemical compounds that facilitate the augmentation of IL-18R's functional activity through distinct biochemical pathways. Anakinra, by blocking IL-1 receptor interaction, indirectly prioritizes IL-18R signaling by reducing the competitive effects of IL-1. This mechanism allows IL-18R to function more prominently in its role within the immune response. Similarly, Poly(I:C) and its TLR3 activation lead to a boost in IFN-γ production, synergizing with IL-18 to potentiate IL-18R activation. The metabolite isopentenyl pyrophosphate engages gamma/delta T cells, which in turn can release cytokines that foster an environment conducive to IL-18R signaling enhancement. The immune response is further modulated by the PPARγ agonist rosiglitazone and the TLR7 agonists resiquimod and imiquimod, which induce cytokine production, thereby indirectly promoting IL-18R activity by influencing the cellular milieu.

The activation of IL-18R is also influenced by agents that stimulate various immune cells to alter cytokine landscapes. CpG oligodeoxynucleotide, a TLR9 agonist, enhances IL-18R expression on natural killer cells, while zymosan and curdlan, through dectin-1 activation, prime the immune system to produce cytokines that cooperate with IL-18 to activate IL-18R pathways. Gardiquimod, another TLR7 agonist, bolsters cytokine production that benefits IL-18R signaling. Additionally, S-27609 impedes dipeptidyl peptidase IV, potentially raising GLP-1 levels that have immunomodulatory effects, thus indirectly supporting IL-18R signaling enhancement. Lastly, alum, an immune adjuvant, shapes the cytokine environment to favor IL-18R signaling, underpinning the array of chemical compounds that indirectly but effectively enhance the functional activity of IL-18R.